Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Director/PDMR Shareholding

22 Mar 2017 10:30

RNS Number : 1937A
Huntsworth PLC
22 March 2017
 

 

22 March 2017

 

Huntsworth plc

(Huntsworth or the Company)

Director/PDMR Shareholding

Huntsworth plc, the healthcare communications and public relations group, announces that on 21 March 2017 (Date of Grant), an award under The Huntsworth Long Term Incentive Plan 2016 was made to Paul Taaffe, Chief Executive Officer, and Neil Jones, Chief Financial Officer, as set out below.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Taaffe

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

HUNTSWORTH PLC

b)

 

LEI

 

 

213800VWB9DDVXF1Q771

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each in the share capital of Huntsworth plc

 

 

 

 

Identification code

GB00B0CRWK29

 

 

b)

 

Nature of the transaction

 

 

Grant of a conditional nil-cost share award over Company shares with a market value equivalent to ÂŁ600,000 at the Date of Grant, under The Huntsworth Long Term Incentive Plan 2016. The number of ordinary shares of 1p each in the capital of the Company granted was determined by the closing middle-market share price on the dealing day before the Date of Grant, being 40.75 pence per share. Vesting is subject to meeting performance conditions relating to earnings per share and relative total shareholder return. Subject to satisfying the relevant performance conditions, the award will normally vest on the third anniversary of the Date of Grant.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil

1,472,392

 

 

 

 

 

 

d)

 

Aggregated information

Not applicable - single transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

21 March 2017

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Neil Jones

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

HUNTSWORTH PLC

b)

 

LEI

 

 

213800VWB9DDVXF1Q771

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence each in the share capital of Huntsworth plc

 

 

 

 

Identification code

GB00B0CRWK29

 

 

b)

 

Nature of the transaction

 

 

Grant of a nil-cost share award over Company shares with a market value equivalent to ÂŁ350,000 at the Date of Grant, under The Huntsworth Long Term Incentive Plan 2016. The number of ordinary shares of 1p each in the capital of the Company granted was determined by the closing middle-market share price on the dealing day before the Date of Grant, being 40.75 pence per share. Vesting is subject to meeting performance conditions relating to earnings per share and relative total shareholder return. Subject to satisfying the relevant performance conditions, the award will normally vest on the third anniversary of the Date of Grant and can be exercised for a period of seven years from the vesting date.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

Nil

858,895

 

 

 

 

 

 

d)

 

Aggregated information

Not applicable - single transaction

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

 

21 March 2017

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

Enquiries to:

 

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Simon Rigby

 

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHJTMLTMBJTMRR
Date   Source Headline
26th Jul 20177:00 amRNSInterim Results for the six months to 30 June 2017
11th Jul 20172:28 pmRNSHolding(s) in Company
6th Jul 20172:04 pmRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSAdditional Listing
4th Jul 20173:33 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSAcquisition of The Creative Engagement Group
29th Jun 20175:53 pmRNSHolding(s) in Company
29th Jun 201712:33 pmRNSDisposal by BlueFocus
22nd Jun 20179:00 amRNSNotice of Interim Results
14th Jun 201711:27 amRNSHolding(s) in Company
2nd Jun 201711:07 amRNSScrip Dividend Alternative
25th May 20172:22 pmRNSResults of Annual General Meeting
25th May 20177:00 amRNSTrading Update
9th May 20175:38 pmRNSHolding(s) in Company
9th May 20179:13 amRNSDirector Declaration
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension
28th Apr 20174:47 pmRNSHolding(s) in Company
28th Apr 201710:48 amRNSHolding(s) in Company
27th Apr 20178:59 amRNSDisposal and lock-up arrangement
25th Apr 20179:30 amRNSNotice of AGM
22nd Mar 201710:30 amRNSDirector/PDMR Shareholding
21st Mar 20177:00 amRNSPreliminary results year ended 31 December 2016
16th Feb 20177:00 amRNSTrading update for year ending 31 December 2016
3rd Feb 20173:27 pmRNSHolding(s) in Company
27th Jan 20174:08 pmRNSNotice of Result & Change to Audit Committee Chair
16th Dec 20164:49 pmRNSDirector/PDMR Shareholding
16th Dec 20163:27 pmRNSHolding(s) in Company
16th Dec 20162:18 pmRNSChange of Auditor
14th Dec 20164:00 pmRNSDirector/PDMR Shareholding
13th Dec 201611:15 amRNSDirector/PDMR Shareholding
9th Dec 20165:10 pmRNSDirector/PDMR Shareholding
6th Dec 20164:21 pmRNSChange of Auditor
6th Dec 20168:18 amRNSHolding(s) in Company
2nd Dec 201612:59 pmRNSBlock listing Interim Review
1st Dec 20161:05 pmRNSTotal Voting Rights
10th Nov 20164:17 pmRNSDirector/PDMR Shareholding
9th Nov 20164:10 pmRNSDirector/PDMR Shareholding
3rd Nov 201610:42 amRNSAdditional Listing
6th Oct 20162:45 pmRNSScrip Dividend Alternative
15th Sep 20162:22 pmRNSHolding(s) in Company
12th Sep 20164:17 pmRNSDirector/PDMR Shareholding
4th Aug 20165:45 pmRNSHolding(s) in Company
4th Aug 201611:28 amRNSHolding(s) in Company
3rd Aug 20164:43 pmRNSHolding(s) in Company
3rd Aug 20162:19 pmRNSHolding(s) in Company
3rd Aug 20162:10 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSTotal Voting Rights
26th Jul 20166:00 pmRNSDirector/PDMR Shareholding
26th Jul 20167:00 amRNSInterim results for the six months to 30 June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.